About Index Trending news
Lists
Pricing
Fate Therapeutics Inc

Fate Therapeutics Inc

Fate Therapeutics Inc

Fate Therapeutics is a stem cell and developmental biology research companyusing biological mechanisms to develop stem cell therapeutics.

Elsewhere

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$10,290,000
Venture capital (Series B)
$35,988,360
Employees

Team size

10+
Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Fate Therapeutics Inc makes some noise.